Headlines

DiabetesHealth – Novo Nordisk Introduces New Insulin Device to U.S. Market

Novo Nordisk has introduced the Levemir® FlexTouch® prefilled insulin delivery device to the U.S. market. The device, filled with insulin detemir [rDNA origin], the first of its kind that does not use a pushbutton extension. In a conventional insulin delivery device, a pushbutton extends out from the device.

Health.com – 15 Exercise Tips for People With Type 2 Diabetes

Exercise is safe—and highly recommended—for most people with type 2 diabetes, including those with complications. Along with diet and medication, exercise will help you lower blood sugar and lose weight.

Diabetes Patients at Increased Risk for Mortality from Chronic Liver Disease

Data from death certificates was collected in Italy from patients (n=176, 771) diagnosed with diabetes and who died from chronic liver disease (CLD). Researchers collected data retrospectively to determine the cause CLD, which led to increased risk of death.

DiabetesInControl – Statins Linked to New Onset TII Diabetes Risk

In a retrospective cohort study, Giovanni Corrao and colleagues from the University of Milano-Bicocca, Italy, evaluated 115,709 individuals who were recently diagnosed with diabetes and treated with statins during the time period of 2003-2004 and followed prospectively until 2010.

Medscape – Is Inhaled Insulin a ‘Game Changer’?

A new formulation of insulin that is delivered via inhaler promises the elimination of needles for patients with diabetes. So why hasn’t there been more fanfare over the anticipated arrival of Afrezza?

NewsFlash: Both ADA and JDRF Getting New CEOs

The tides are a changin’ at two of the top diabetes orgs, with both the JDRF and the American Diabetes Association getting new leaders this month for the first time in years.

US News – Study Links Shift Work to Risk for Type 2 Diabetes

Shift workers, especially men, may be at higher risk for type 2 diabetes compared to people not on such schedules, a new study suggests. Also at special risk are shift workers who don’t work on a set schedule, with shifts moving around at various times of the day.

DiabetesMine – New Tallygear Review in the Test Kitchen!

It’s been about three months since we launched the DiabetesMine Test Kitchen, a central hub for people with diabetes to share their experiences TestKitchen_Logo_Final_lg (1)with products created to improve life with this illness. Today, we’ve added another great new review from D-blogger and advocate Melissa Lee.

Huffpost – Are These 10 Trendy Health Foods Worth The Hype?

We talked to Keri Gans, R.D., author of “The Small Change Diet,” to walk us through some of the more trendy health foods to explain what they are exactly, why we eat them, and whether they’re actually worth the hype.

TIME – Having The Right Kind of Fat Can Protect Against Diabetes, Study Says

A report published in the journal Diabetes, scientists led by Labros Sidossis, professor of internal medicine at University of Texas Medical Branch at Galveston, found for the first time that adults who retained more amounts of brown fat were better able to keep blood sugar under control and burn off fat stores.

Insulin Nation – 5 Tips to Better Exercise with Type 1 Diabetes

There is no doubt that exercising with diabetes is about one million times more challenging than exercising without diabetes, particularly if you take insulin. Low blood sugars and high blood sugars are major party-poopers in the middle of a walk, yoga, spinning class, tai chi, or strength-training.

DiabetesMine – Have Professional CGMs Passed Their Prime?

Should people with diabetes always have access to their diabetes data and be able to react, or is it better at times to “fly blind” and leave the data-based decision-making in the doctor’s hands?

High-Salt Diet May Double Diabetics’ Heart Disease Risk

It’s not only sugar that raises alarms for people with diabetes. Eating a high-salt diet may double the risk of developing heart disease in people with diabetes, according to a new study from Japan.

iMedicalApps – What the iPhone based ‘Artificial Pancreas’ means to patients and physicians

At the recent 74th annual American Diabetes Association Scientific Session in San Francisco, results from a simultaneously published article in the New England Journal of Medicine were formally announced. The publication consisted of two separate studies demonstrating the efficacy and safety of an “artificial” or “bionic” pancreas for people with type 1 diabetes.

NewsFlash: Insulin Release Band-Aid Sized Encapsulation Device Goes to FDA!

The trial would evaluate the safety and efficacy of a new stem cell-derived encapsulated cell replacement therapy, known officially as VC-O1. Basically, that product uses pancreas endoderm cells derived from embryonic stem cells and would be put into the body using something called the Encaptra delivery system.

CNN – 5 things you didn’t know about Alzheimer’s

In the fight against these fast-growing numbers, experts from all over the world discussed the latest research at the Alzheimer’s Association International Conference in Copenhagen, Denmark, this week. Here are five things we learned about Alzheimer’s disease and other forms of dementia.

Huffpost – Portion Alert: 5 Healthy Foods You Can Easily Overeat

It is possible that eating too many of even the right foods can prevent you from losing weight. Hence, the need for a reality check and tips for portion control!

Research: Treating Diabetic Macular Edema with an Implant

A study was then done to present the safety and efficacy of intravitreal implants releasing 0.2mcg/day of fluocinolone acetonide (FAc) in patients which chronic versus nonchronic DME. Chronic was defined as a diagnoses of DME for 3 years or greater while a diagnoses if DME for less than 3 years was characterized as nonchronic.

DiabetesInControl – Are Insulin Pumps a Better Choice than Multiple Insulins for Type 2’s?

Patients in the study all had uncontrolled type 2 diabetes and were between the ages 30 to 75. Results showed that after 6 months, patients with an insulin pump had a significantly greater decrease in their average blood glucose levels compared to the patients who had multiple injections per day.

Potential Benefits of Glutamine Supplementation for Type 2 Diabetes

According to studies, type 2 diabetic patients have significantly lower concentrations of the amino acid glutamine circulating in the body.



Other News

ACLS Class

  • Get ACLS and PALS certified online with ACLSclass.com’s fast programs.
  • Health Partner